Humacyte

HUMA · NASDAQ🇺🇸

Overview

Earnings Dividends Seasonality Metrics

NOV

12

Q3 2025

Reported

Reported earnings 3 months ago

Previous year: -$0.33

-66.7%

Hospitals with VAC approval

25

Hospitals in VAC review

45

V012 Trial Enrollment

109

Cash and Equivalents

$19.5M

Previous year: $20.6M

Loading...

Humacyte

Unlock previous datapoints

Upgrade

Humacyte

Unlock previous datapoints

Upgrade

Humacyte Revenue by Segment

Revenue by Segment

Product Revenue

CapyFin.com

Contract Revenue

CapyFin.com

Historical Earnings Impact

Analyze how earnings announcements historically affect stock price performance

Avg. Return Before/After Earnings

Loading earnings performance data...

Loading earnings reaction data...

Key Statistics

Market Cap

$193M

P/E Ratio

-3.83

Sector

N/A

Industry

N/A

52-Week High

$4.11

52-Week Low

$0.869

Hospitals with VAC approval

25

Hospitals in VAC review

45

V012 Trial Enrollment

109

Net proceeds from equity raise

$56.5M

Products

Get in Touch

Resources

Humacyte

Humacyte

Humacyte

Humacyte Revenue by Segment

Revenue by Segment

Product Revenue

Contract Revenue

Historical Earnings Impact

Avg. Return Before/After Earnings

Key Statistics